Key result
Glial fibrillary acidic protein may be a reliable neuromarker for acute brain injury in children after cardiac surgery, whereas neuron-specific enolase and brain-derived neurotrophic factor are not.
Why the study?
Data regarding neuromarkers used to evaluate the impact of cardiovascular surgery on the neurodevelopmental pattern of children with congenital heart defects needed assessment.
Do neuromarkers predict neurodevelopmental impairment in children with congenital heart defects after cardiac surgery?
Systematic Review (n=471)
Do neuromarkers predict neurodevelopmental impairment in children with congenital heart defects after cardiac surgery?
Glial fibrillary acidic protein (GFAP) may serve as a reliable neuromarker for acute brain injury in children undergoing cardiac surgery for congenital heart defects.
May inform perioperative neuromonitoring in congenital heart surgery; extends biomarker data but requires prospective validation.
The aim of this systematic literature review was to assess the data regarding neuromarkers used to evaluate the impact of cardiovascular surgery on neurodevelopmental pattern of children with congenital heart defects. A systematic search was performed on PubMed and Google Scholar databases. Out of 713 publications screened, 10 studies (471 patients) met the inclusion criteria. The included studies were coded on several variables: number and heterogeneity of patients (age, congenital heart defects), exclusion of patients with conditions that predispose to neurological impairment, neuroimaging workup pre- and post-surgery, neurodevelopmental assessment, interventions (part of a different study), and follow-up period. Results were reported according to PRISMA guidelines. Findings include: neuron-specific enolase and brain-derived neurotrophic factor are not reliable neuromarkers, for protein S100B different results were reported, for activin A there is lack of evidence, and glial fibrillary acidic protein could represent a reliable neuromarker for acute brain-injury. Directions for future research are discussed.
No takes yet. Share an insight, caveat, or question.
Chiperi et al. (2023) conducted a systematic review in congenital heart defects (n=471). Neuromarkers was evaluated on Neurodevelopmental impairment. Glial fibrillary acidic protein may be a reliable neuromarker for acute brain injury in children after cardiac surgery, whereas neuron-specific enolase and brain-derived neurotrophic factor are not.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: